Accelerate Diagnostics Q3 EPS $(0.37) Beats $(0.38) Estimate, Sales $2.271M Miss $3.12M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 9.76 percent increase over losses of $(0.41) per share

Benzinga · 11/07/2019 21:20

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 9.76 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $2.271 million which missed the analyst consensus estimate of $3.12 million by 27.21 percent. This is a 67.60 percent increase over sales of $1.355 million the same period last year.